Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review

[1] Chang CH(2020)Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 395 709-733

[2] Fan PC(2020)Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study Sci Rep. 10 2938-37

[3] Kuo G(2020)Nephrotoxicity of antimicrobials and antibiotics Adv Chronic Kidney Dis 27 31-636

[4] Morales-Alvarez MC(2012)Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction? Ren Fail 34 634-1083

[5] Kocyigit I(2014)DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58 1072-398

[6] Dortdudak S(2007)Identifying patients at risk of chronic kidney disease Am Fam Physician 76 1454-1009

[7] Sipahioglu M(2016)Influence of kidney disease on drug disposition: an assessment of industry studies submitted to the FDA for new chemical entities 1999–2010 J Clin Pharmacol 56 390-503

[8] Roberts JA(2010)Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size Clin J Am Soc Nephrol 5 1003-20

[9] Paul SK(2020)Evolution of equations for estimating renal function and their application to the dosing of new antimicrobials Ann Pharmacother 54 496-344

[10] Akova M(2018)Pragmatic use of kidney function estimates for drug dosing: the tide is turning Adv Chronic Kidney Dis 25 14-193

[1] Chang CH(2020)Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 395 709-733

[2] Fan PC(2020)Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study Sci Rep. 10 2938-37

[3] Kuo G(2020)Nephrotoxicity of antimicrobials and antibiotics Adv Chronic Kidney Dis 27 31-636

[4] Morales-Alvarez MC(2012)Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction? Ren Fail 34 634-1083

[5] Kocyigit I(2014)DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58 1072-398

[6] Dortdudak S(2007)Identifying patients at risk of chronic kidney disease Am Fam Physician 76 1454-1009

[7] Sipahioglu M(2016)Influence of kidney disease on drug disposition: an assessment of industry studies submitted to the FDA for new chemical entities 1999–2010 J Clin Pharmacol 56 390-503

[8] Roberts JA(2010)Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size Clin J Am Soc Nephrol 5 1003-20

[9] Paul SK(2020)Evolution of equations for estimating renal function and their application to the dosing of new antimicrobials Ann Pharmacother 54 496-344

[10] Akova M(2018)Pragmatic use of kidney function estimates for drug dosing: the tide is turning Adv Chronic Kidney Dis 25 14-193